You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 56 No. 9, September 1999 TABLE OF CONTENTS
  Archives
  •  Online Features
  Neurological Review
 This Article
 •Full text
 •PDF
 •Correction
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (20)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Movement Disorders
 •Parkinson Disease/ Parkinsonian Disorders
 •Alert me on articles by topic

Stereotactic Pallidotomy in the Treatment of Parkinson Disease

An Expert Opinion

Jeff M. Bronstein, MD, PhD; Antonio DeSalles, MD, PhD; Mahlon R. DeLong, MD; for the Workshop Participants

Arch Neurol. 1999;56:1064-1069.

The objective of this workshop was to provide recommendations on several issues involving pallidotomy for patients with medically intractable Parkinson disease to physicians, patients, and other health care providers. An international consortium of experts in neurology, neurosurgery, and neurophysiology who had extensive experience with pallidotomy were invited to the workshop. Participants were sent background materials from the scientific literature for review-based participant recommendations. A proposed agenda was circulated to all participants before the workshop, and the final agenda was based on their recommendations. Topics were introduced at the workshop by members of the organizing committee, followed by extensive group discussion. A draft of a consensus statement, based on the previous day's discussion, was circulated and further modifications were made. The final statement was agreed on by all members.The conclusions of the participants were: (1) Pallidotomy should be performed only at centers that have a team of physicians with substantial expertise and experience in the field. (2) Patients with disabling idiopathic Parkinson disease, without dementia, and who have exhausted medical therapy should be considered for pallidotomy. (3) All patients should be examined by means of standardized rating scales both preoperatively and postoperatively to ensure quality of care at each center. (4) Symptoms that respond best to pallidotomy include medication-induced dyskinesias, rigidity, and tremor, while balance, gait disorders, and hypophonia are generally less responsive to surgery. Benefits of pallidotomy appear to be long lasting. (5) Each institution's complication rate should be discussed before surgery.


From the Departments of Neurology (Dr Bronstein) and Neurosurgery (Dr DeSalles) and the Brain Research Institute (Drs Bronstein and DeSalles), University of California, Los Angeles, School of Medicine; and Department of Neurology, Emory School of Medicine, Atlanta, Ga (Dr DeLong).


RELATED ARTICLE

Archives of Neurology Reader's Choice: Continuing Medical Education
Arch Neurol. 1999;56(9):1169-1171.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Bilateral subthalamotomy in Parkinson's disease: initial and long-term response
Alvarez et al.
Brain 2005;128:570-583.
ABSTRACT | FULL TEXT  

Bilateral pallidotomy for treatment of Parkinson's disease induced corticobulbar syndrome and psychic akinesia avoidable by globus pallidus lesion combined with contralateral stimulation
Merello et al.
J. Neurol. Neurosurg. Psychiatry 2001;71:611-614.
ABSTRACT | FULL TEXT  

Pathophysiology of bradykinesia in Parkinson's disease
Berardelli et al.
Brain 2001;124:2131-2146.
ABSTRACT | FULL TEXT  

Outcome of unilateral pallidotomy in advanced Parkinson's disease: cohort study of 32 patients
de Bie et al.
J. Neurol. Neurosurg. Psychiatry 2001;71:375-382.
ABSTRACT | FULL TEXT  

Long-term efficacy of posteroventral pallidotomy in the treatment of Parkinson's disease
Lai et al.
Neurology 2000;55:1218-1222.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1999 American Medical Association. All Rights Reserved.